Status:

NOT_YET_RECRUITING

Primary Prophylaxis of Clostridioides Difficile Infection With Oral Vancomycin

Lead Sponsor:

University of Maryland, Baltimore

Collaborating Sponsors:

University of Maryland, Baltimore Washington Medical Center

Conditions:

Clostridioides Difficile

Vancomycin Resistance Enterococcus Faecium

Eligibility:

All Genders

65-100 years

Phase:

PHASE2

PHASE3

Brief Summary

The purpose of this study is to evaluate the ability of oral vancomycin in preventing Clostridioides difficile infection (CDI) in patients that are simultaneously receiving antibiotics. Participants ...

Detailed Description

This research study is being conducted to evaluate the feasibility of prescribing oral vancomycin in preventing CDI in patients who are receiving concomitant systemic antibiotics. There are two group...

Eligibility Criteria

Inclusion

  • Age 65 years or older
  • Receive systemic antibiotics in the last 90 days
  • Hospitalized anywhere in the last 90 days
  • History of C diff colonization without history of C diff colitis (infection)
  • Provide informed consent
  • Read and understand the English language
  • Not current taking probiotics
  • Lack of allergy or contraindications to receive vancomycin
  • Ability to take oral medications
  • Not receiving medications that can be used to treat or prevent C diff

Exclusion

  • Age 64 years or younger
  • Has not received systemic antibiotics in the last 90 days
  • Has not been hospitalized in the last 90 days
  • History of C diff colonization with a history of C diff colitis (infection)
  • Not provided informed consent
  • Cannot read and understand the English language
  • Currently receiving probiotics
  • Allergy or contraindications to receive vancomycin
  • Unable to take oral medications
  • Receiving medications that can be used to treat or prevent C diff

Key Trial Info

Start Date :

March 1 2026

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 31 2027

Estimated Enrollment :

200 Patients enrolled

Trial Details

Trial ID

NCT07221708

Start Date

March 1 2026

End Date

December 31 2027

Last Update

January 7 2026

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Maryland Baltimore Washington Medical Center

Glen Burnie, Maryland, United States, 21061

Primary Prophylaxis of Clostridioides Difficile Infection With Oral Vancomycin | DecenTrialz